Moving Analytics Inc.

Belkins
We provide intuitive, turnkey, home-based post-acute care management solutions for cardiopulmonary disease that improves patient outcomes, reduces readmissions and empowers the effective and efficient delivery of quality care to patients based on 30+ years of research in remote disease management from Stanford University.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PROTECTIVE CLOTHING FOR LIFE SCIENCES INDUSTRY GLOBAL MARKET TO WITNESS GROWTH IN BIOTECHNOLOGY AND HEALTHCARE SPENDING BY 2028

Research And Markets | June 30, 2020

news image

The "Global Protective Clothing Market for Life Sciences Industry 2019-2028" report has been added to ResearchAndMarkets.com's offering.The publisher predicts that the global market for protective clothing for life sciences industry would witness a CAGR of 6.26% over the forecast period 2019-2028.The growth of this market is primarily being driven by the growing demand for protective clothing from end-users. Additionally, the large investments in research & developm...

Read More

INDUSTRIAL IMPACT

TARA BIOSYSTEMS PARTNERS WITH SCIPHER MEDICINE®

TARA Biosystems | November 03, 2021

news image

TARA Biosystemsa, biotechnology company harnessing human biology and data to transform cardiac drug discovery, today announced a collaboration with Scipher Medicine, a precision medicine company matching patients with the most effective therapy. The collaboration will address a critical unmet need for effective therapeutics in cardiac laminopathies. Cardiac laminopathies, associated with mutations in the LMNA gene, can result in electrical and mechanical changes in the heart. Thes...

Read More

AMYRIS COLLABORATES WITH INFECTIOUS DISEASE RESEARCH INSTITUTE TO ADVANCE A NOVEL RIBONUCLEIC ACID VACCINE PLATFORM WITH COVID-19 VACCINE

Amyris | October 23, 2020

news image

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced the signing of a Collaboration Agreement and License Agreement with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine. The collaboration will combine IDRI's RNA vacci...

Read More

CIPLA AND STEMPEUTICS JOIN FORCES FOR THE LAUNCH OF STEMPEUCEL® IN INDIA

Cipla | August 24, 2020

news image

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first ste...

Read More
news image

PROTECTIVE CLOTHING FOR LIFE SCIENCES INDUSTRY GLOBAL MARKET TO WITNESS GROWTH IN BIOTECHNOLOGY AND HEALTHCARE SPENDING BY 2028

Research And Markets | June 30, 2020

The "Global Protective Clothing Market for Life Sciences Industry 2019-2028" report has been added to ResearchAndMarkets.com's offering.The publisher predicts that the global market for protective clothing for life sciences industry would witness a CAGR of 6.26% over the forecast period 2019-2028.The growth of this market is primarily being driven by the growing demand for protective clothing from end-users. Additionally, the large investments in research & developm...

Read More
news image

INDUSTRIAL IMPACT

TARA BIOSYSTEMS PARTNERS WITH SCIPHER MEDICINE®

TARA Biosystems | November 03, 2021

TARA Biosystemsa, biotechnology company harnessing human biology and data to transform cardiac drug discovery, today announced a collaboration with Scipher Medicine, a precision medicine company matching patients with the most effective therapy. The collaboration will address a critical unmet need for effective therapeutics in cardiac laminopathies. Cardiac laminopathies, associated with mutations in the LMNA gene, can result in electrical and mechanical changes in the heart. Thes...

Read More
news image

AMYRIS COLLABORATES WITH INFECTIOUS DISEASE RESEARCH INSTITUTE TO ADVANCE A NOVEL RIBONUCLEIC ACID VACCINE PLATFORM WITH COVID-19 VACCINE

Amyris | October 23, 2020

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced the signing of a Collaboration Agreement and License Agreement with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine. The collaboration will combine IDRI's RNA vacci...

Read More
news image

CIPLA AND STEMPEUTICS JOIN FORCES FOR THE LAUNCH OF STEMPEUCEL® IN INDIA

Cipla | August 24, 2020

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger's Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first ste...

Read More